Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Shigeta K, Hasegawa H, Okabayashi K, Tsuruta M, Ishii Y, Endo T. et al.
Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer.

Int J Cancer 2016;
139: 946-54

Bibliographische Angaben herunterladen

Aufrufen in: